乙型重型肝炎抗病毒治疗研究进展

Anti-virus therapy for fulminant hepatitis B

通过抗病毒治疗降低乙型重型肝炎患者机体HBV载量,缓解过强的免疫反应,从而缓解病情,成为治疗乙型重型肝炎的一种可行性思路。但目前对此仍存在争议。文中就目前乙型重型肝炎是否行抗病毒治疗,抗病毒治疗的时机、特点以及药物的选择等方面进行了综述。

To patients of fulminant hepatitis B, several researchers found that anti-vires therapy could lower the level of HBV-DNA and lighten the immune reaction, it consequently improved the prognosis. But at the meantime there are an objection to this statement. This article reviews the advances in recent years of whether to, when to, and what drugs to select to give anti-vires therapy to those patients of fulminant hepatitis B and so on.